Neurocrine Biosciences
NBIX
#1271
Rank
$12.07 B
Marketcap
$125.58
Share price
-0.58%
Change (1 day)
55.44%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2022 (TTM): $94.8 M

According to Neurocrine Biosciences 's latest financial reports the company's current earnings (TTM) are $94.8 M. In 2021 the company made an earning of $0.12 B a decrease over its 2020 earnings that were of $0.13 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$94.8 M-25.47%
2021$0.12 B-8.82%
2020$0.13 B77.7%
2019$78.5 M49.9%
2018$52.37 M-142.02%
2017-$0.13 B-15.44%
2016-$0.15 B56.44%
2015-$94.21 M46.25%
2014-$64.42 M29.66%
2013-$49.68 M-3530.8%
2012$1.44 M-95.73%
2011$33.92 M
2009-$47.69 M-45.38%
2008-$87.3 M-58.87%
2007-$0.22 B87.3%
2006-$0.12 B351.97%
2005-$25.08 M-52.09%
2004-$52.34 M-10.98%
2003-$58.79 M-43.26%
2002-$0.11 B136.12%
2001-$43.89 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$34.92 B 36,738.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.78 B 15,493.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.54 B 6,809.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.20 B 116.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-$84.54 M-189.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-$82.7 M-187.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-$36.17 M-138.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.08 B 1,041.09%๐Ÿ‡ฌ๐Ÿ‡ง UK